A World Allergy Organization international survey on diagnostic procedures and therapies in drug allergy/hypersensitivity

World Allergy Organization Journal

Volumn 4, Issue 12, 2011, Pages 257-270

  Thong, Bernard Yu Hor ^a   Mirakian, Rita ^b   Castells, Mariana ^c   Pichler, Werner ^d   Romano, Antonino ^e   Bonadonna, Patrizia ^f   Diana, Deleanu ^g   Kowalski, Marek ^h   Yanez, Anahi ⁱ   Lleonart, Ramon ^j   Sanchez Borges, Mario ^k   Demoly, Pascal ^l  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF BERN   (Switzerland)

^e OASI RESEARCH INSTITUTE IRCCS   (Italy)

^f UNIVERSITY HOSPITAL OF VERONA   (Italy)

^g IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^h MEDICAL UNIVERSITY OF LODZ   (Poland)

ⁱ Hospital Aeronautico Central   (Argentina)

^j HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^k Clinica El Avila   (Venezuela)

^l HÔPITAL ARNAUD DE VILLENEUVE   (France)

more..

Author keywords

Desensitization; Drug allergy; Hypersensitivity; Skin tests

Indexed keywords

ABACAVIR; ANTIBIOTIC AGENT; CARBAMAZEPINE; CORTICOSTEROID; HLA ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; PENICILLIN DERIVATIVE;

ARTICLE; BASOPHIL; CHEMOTHERAPY; CORTICOSTEROID THERAPY; DESENSITIZATION; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; HEALTH CARE ORGANIZATION; HEALTH SURVEY; HUMAN; IN VITRO STUDY; MEDICAL SOCIETY; PATCH TEST; PRIORITY JOURNAL; PROVOCATION TEST; QUESTIONNAIRE; SKIN TEST; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

EID: 84856397399     PISSN: 19394551     EISSN: None     Source Type: Journal    
DOI: 10.1097/WOX.0b013e31823dc02c     Document Type: Article

References (68)

1. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113:832-836. (Pubitemid 38608590)
2. Dietrich JJ, Quinn JM, England RW. Reasons for outpatient consultation in allergy/immunology. Allergy Asthma Proc. 2009;30:69-74.
3. England RW, Ho TC, Napoli DC, Quinn JM. Inpatient consultation of allergy/immunology in a tertiary care setting. Ann Allergy Asthma Immunol. 2003;90:393-397. (Pubitemid 36459043)
4. Dantonio C, Galimberti M, Barbone B, Calamari M, Airoldi G, et al. Suspected acute allergic reactions: analysis of admissions to the Emergency Department of the AOU Maggiore della Carità Hospital in Novara from 2003 to 2007. Eur Ann Allergy Clin Immunol. 2008;40:122-129.
5. Dietrich JJ, Quinn JM, England RW. Reasons for outpatient consultation in allergy/immunology. Allergy Asthma Proc. 2009;30:69-74.
6. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129:92-96. (Pubitemid 23029676)
7. Rzany B, Hering O, Mockenhaupt M, Schröder W, Goerttler E, Ring J, Schöpf E. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. 1996;135:6-11. (Pubitemid 26225106)
8. Halevy S. Acute generalized exanthematous pustulosis. Curr Opin Allergy Clin Immunol. 2009;9:322-328.
9. Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, et al. Second symposium on the definition and management of anaphylaxis: summary reportdsecond National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117:391-397. (Pubitemid 43190153)
10. Warner JO, Kaliner MA, Crisci CD, Del Giacco S, Frew AJ, et al. World Allergy Organization Specialty and Training Council. llergy practice worldwide: a report by the World Allergy Organization Specialty and Training Council. Int Arch Allergy Immunol. 2006;139:166-174. (Pubitemid 43177330)
11. Potter PC, Warner JO, Pawankar R, Kaliner MA, Giacco SD, Rosenwasser L, on behalf of the WAO Specialty and Training Council Recommendations for Competency in Allergy Training for Undergraduates Qualifying as Medical Practitioners. A Position Paper of the World Allergy Organization. WAO J. 2009;2:150-154.
12. American Academy of Allergy, Asthma and Immunology. Consultation and referral guidelines citing the evidence: how the allergist-immunologist can help. J Allergy Clin Immunol. 2006;117(2 suppl Consultation):S495-S523.
13. Bernstein IL, Li JT, Bernstein DI, Hamilton R, Spector SL, et al. American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol. 2008;100(3 suppl. 3):S1-S148.
14. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Picado C, et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy. 2007;62:1111-1118. (Pubitemid 47374015)
15. Aberer W, Bircher A, Romano A, Blanca M, Campi P, et al. European Network for Drug Allergy (ENDA); EAACI Interest Group on Drug Hypersensitivity. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy. 2003;58:854-863. (Pubitemid 37046682)
16. Mirakian R, Ewan PW, Durham SR, Youlten LJ, Dugué P, et al. BSACI. BSACI guidelines for the management of drug allergy. Clin Exp Allergy. 2009;39:43-61.
17. Torres MJ, Blanca M. European Network for Drug Allergy (ENDA); EAACI Interest Group on Drug Hypersensitivity. Importance of skin testing with major and minor determinants of benzylpenicillin in the diagnosis of allergy to betalactams. Statement from the European Network for Drug Allergy concerning AllergoPen withdrawal. Allergy. 2006;61:910-911. (Pubitemid 44024886)
18. Romano A, Blanca M, Torres MJ, Bircher A, et al. EAACI. Diagnosis of non-immediate reactions to beta-lactam antibiotics. Allergy. 2004;59:1153-1160. (Pubitemid 39389467)
19. Torres MJ, Blanca M, Fernandez J, Romano A, Weck A, et al. ENDA; EAACI Interest Group on Drug Hypersensitivity. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy. 2003;58:961-972. (Pubitemid 37260337)
20. Brockow K, Christiansen C, Kanny G, Clément O, Barbaud A, et al. ENDA; EAACI Interest Group on Drug Hypersensitivity. Management of hypersensitivity reactions to iodinated contrast media. Allergy. 2005;60:150-158. (Pubitemid 40187467)
21. Executive summary of disease management of drug hypersensitivity: a practice parameter. Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology, the American Academy of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1999;83 (6 pt 3):665-700.
22. American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology. Contact dermatitis: a practice parameter. Ann Allergy Asthma Immunol. 2006;97(3 suppl 2):S1-38.
23. Mertes PM, Laxenaire MC, Lienhart A, Aberer W, Ring J, Pichler WJ, Demoly P. Working Group for the SFAR; ENDA; EAACI Interest Group on Drug Hypersensitivity. Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice. J Investig Allergol Clin Immunol. 2005;15:91-101.
24. Barbaud A, Gonçalo M, Bruynzeel D, Bircher A. European Society of Contact Dermatitis. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis. 2001;45:321-328. (Pubitemid 34056345)
25. Wilkinson DS, Fregert S, Magnusson B, Bandmann HJ, Calnan CD, et al. Terminology of contact dermatitis. Acta Dermato-Venereologica. 1970;50:287-292.
26. Harper NJ, Dixon T, Dugué P, Edgar DM, Fay A, et al. Working Party of the Association of Anaesthetists of Great Britain and Ireland. Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia. 2009;64:199-211.
27. Sturkenboom M, Nicolosi A, Cantarutti L, Mannino S, Picelli G, Scamarcia A, Giaquinto C. NSAIDs Paediatric Research Group. Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics. Pediatrics. 2005;116:e26-e33.
28. Rebelo Gomes E, Fonseca J, Araujo L, Demoly P. Drug allergy claims in children: from self-reporting to confirmed diagnosis. Clin Exp Allergy. 2008;38:191-198. (Pubitemid 350233390)
29. Ponvert C, Weilenmann C, Wassenberg J, Walecki P, Bourgeois ML, de Blic J, Scheinmann P. Allergy to betalactam antibiotics in children: a prospective follow-up study in retreated children after negative responses in skin and challenge tests. Allergy. 2007;62:42-46. (Pubitemid 44902733)
30. Kidon MI, Liew WK, Chiang WC, Lim SH, Goh A, Tang JP, Chay OM. Hypersensitivity to paracetamol in Asian children with early onset of nonsteroidal anti-inflammatory drug allergy. Int Arch Allergy Immunol. 2007;144:51-56. (Pubitemid 47237669)
31. Tan VA, Gerez IF, Van Bever HP. Prevalence of drug allergy in Singaporean children. Singapore Med J. 2009;50:1158-1161.
32. Caubet JC, Kaiser L, Lemaître B, Fellay B, Gervaix A, Eigenmann PA. The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge. J Allergy Clin Immunol. 2011;127:218-222.
33. Ponvert C, Perrin Y, Bados-Albiero A, Le Bourgeois M, Karila C, et al. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol. 2011;22:411-418.
34. Matheu V, Pérez-Rodriguez E, Sánchez-Machin I, de la Torre F, García-Robaina JC. Major and minor determinants are high-performance skin tests in beta-lactam allergy diagnosis. J Allergy Clin Immunol. 2005;116:1167-1168.
35. Bousquet PJ, Co-Minh HB, Arnoux B, Daures JP, Demoly P. Importance of minor determinants and benzylpenicilloyl poly-L-lysine skin testing in the diagnosis of beta-lactam allergy. J Allergy Clin Immunol. 2005;115:1314-1316. (Pubitemid 40824609)
36. Matheu V, Pérez E, González R, Poza P, de la Torre F, Sánchez-Machín I, García-Robaina JC. Assessment of a new brand of determinants for skin testing in a large group of patients with suspected betalactam allergy. J Investig Allergol Clin Immunol. 2007;17:257-260. (Pubitemid 47330069)
37. Romano A, Viola M, Bousquet PJ, Gaeta F, Valluzzi R, Caruso C, Demoly P. A comparison of the performance of two penicillin reagent kits in the diagnosis of beta-lactam hypersensitivity. Allergy. 2007;62:53-58. (Pubitemid 44902735)
38. Barbaud A. Skin testing in delayed reactions to drugs. Immunol Allergy Clin North Am. 2009;29:517-535.
39. Friedmann PS, Ardern-Jones M. Patch testing in drug allergy. Cur Op Allergy Clin Immunol. 2010;10:291-296.
40. Lochmatter P, Zawodniak A, Pichler WJ. In vitro tests in drug hypersensitivity diagnosis. Immunol Allergy Clin North Am. 2009;29:537-554.
41. Aberer W, Krönke B. Provocation tests in drug hypersensitivity. Immunol Allergy Clin North Am. 2009;29:567-584.
42. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med. 2004;140:1001-1006.
43. Blanca-López N, Zapatero L, Alonso E, Torres MJ, Fuentes V, Martínez-Molero MI, Blanca M. Skin testing and drug provocation in the diagnosis of nonimmediate reactions to aminopenicillins in children. Allergy. 2009;64:229-233.
44. Bousquet PJ, Pipet A, Bousquet-Rouanet L, Demoly P. Oral challenges are needed in the diagnosis of beta-lactam hypersensitivity. Clin Exp Allergy. 2008;38:185-190. (Pubitemid 350233388)
45. Torres MJ, Mayorga C, Leyva L, Guzman AE, Cornejo-García JA, Juarez C, Blanca M. Controlled administration of penicillin to patients with a positive history but negative skin and specific serum IgE tests. Clin Exp Allergy. 2002;32:270-276. (Pubitemid 34429607)
46. Caimmi S, Galéra C, Bousquet-Rouanet L, Arnoux B, Demoly P, Bousquet PJ. Safety of cefuroxime as an alternative in patients with a proven hypersensitivity to penicillins: a DAHD Cohort Survey. Int Arch Allergy Immunol. 2010;153:53-60.
47. Bavbek S, Dursun AB, Dursun E, Eryilmaz A, Misirligil Z. Safety of meloxicam in aspirin-hypersensitive patients with asthma and/or nasal polyps. A challenge-proven study. Int Arch Allergy Immunol. 2007;142:64-69. (Pubitemid 46032986)
48. El Miedany Y, Youssef S, Ahmed I, El Gaafary M. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirinexacerbated respiratory disease. Ann Allergy Asthma Immunol. 2006;97:105-109. (Pubitemid 44156346)
49. Celik G, Erkekol FO, Bavbek S, Dursun B, Misirligil Z. Long-term use and tolerability of cyclooxygenase-2 inhibitors in patients with analgesic intolerance. Ann Allergy Asthma Immunol. 2005;95:33-37. (Pubitemid 41022770)
50. Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema. Ann Allergy Asthma Immunol. 2005;95:154-158. (Pubitemid 41170176)
51. Muratore L, Ventura M, Calogiuri G, Calcagnile F, Quarta E, Muratore M, Ferrannini A. Tolerance to etoricoxib in 37 patients with urticaria and angioedema induced by nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol. 2007;98:168-171. (Pubitemid 46214223)
52. Castells M. Rapid desensitization for hypersensitivity reactions to medications. Immunol Allergy Clin North Am. 2009;29:585-606.
53. Cernadas JR, Brockow K, Romano A, Aberer W, Torres MJ, et al. European Network of Drug Allergy and the EAACI Interest Group on Drug Hypersensitivity. General considerations on rapid desensitization for drug hypersensitivityda consensus statement. Allergy. 2010;65:1357-1366.
54. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010;105:259-273.
55. Macy E, Bernstein JA, Castells MC, Gawchik SM, Lee TH, et al. Aspirin Desensitization Joint Task Force. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol. 2007;98:172-174. (Pubitemid 46214224)
56. Wong JT, Nagy CS, Krinzman SJ, Maclean JA, Bloch KJ. Rapid oral challenge-desensitization for patients with aspirin-related urticaria- angioedema. J Allergy Clin Immunol. 2000;105:997-1001. (Pubitemid 30324410)
57. Silberman S, Neukirch-Stoop C, Steg PG. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting. Am J Cardiol. 2005;95:509-510. (Pubitemid 40247551)
58. Rossini R, Angiolillo DJ, Musumeci G, Scuri P, Invernizzi P, Bass TA, Mihalcsik L, Gavazzi A. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation. Am J Cardiol. 2008;101:786-789.
59. French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int. 2006;55:9-16.
60. Wolf R, Davidovici B. Severe cutaneous adverse drug reactions: who should treat, where and how: Facts and controversies. Clin Dermatol. 2010;28:344-348.
61. Gerull R, Nelle M, Schaible T. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review. Crit Care Med. 2011;39:1521-1532.
62. Yip LW, Thong BY, Lim J, Tan AW, Wong HB, Handa S, Heng WJ. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series. Allergy. 2007;62:527-531. (Pubitemid 46608353)
63. Kim SH, Ye YM, Palikhe NS, Kim JE, Park HS. Genetic and ethnic risk factors associated with drug hypersensitivity. Curr Opin Allergy Clin Immunol. 2010;10:280-290.
64. *5701 screening for hypersensitivity to abacavir. N Engl J Med. 2008;358:568-579. (Pubitemid 351214284)
65. Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics. 2006;16:297-306.
66. *5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A. 2005;102:4134-4139. (Pubitemid 40388568)
67. Fernando SL, Broadfoot AJ. Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening. CMAJ. 2010;182:476-480.
68. Gomes ER, Pichler WJ, Demoly P, Aberer W, Frew AJ, De Weck A, and the EAACI Interest Group on Drug Hypersensitivity. The Drug Ambassador Project. The diversity of diagnostic procedures for drug allergy around Europe. Allergy Clin Immunol. 2005;17:9-18. (Pubitemid 40392773)